| pubmed-article:10567877 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C1996904 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C1880497 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0206031 | lld:lifeskim |
| pubmed-article:10567877 | lifeskim:mentions | umls-concept:C0439165 | lld:lifeskim |
| pubmed-article:10567877 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10567877 | pubmed:dateCreated | 2000-1-7 | lld:pubmed |
| pubmed-article:10567877 | pubmed:abstractText | The use of prostate-specific antigen (PSA) in the diagnosis of prostate cancer is controversial due to false-positive results caused by benign prostatic hyperplasia. Several groups have suggested the usefulness of the percentage of free PSA (%fPSA) in patients with PSA levels between 4 and 10 microg/l. Based on previously obtained results, biopsy is carried out in our hospital if the PSA is greater than 10 microg/l or if the %fPSA is lower than 20% and PSA is between 4-10 microg/l. In this study, we have compared these results with those obtained with a logistic regression model based on the determination of PSA and %fPSA. The diagnostic efficacy of the logistic regression model is greater than that of the currently used model. The posterior construction of a nomogram based on the data obtained greatly facilitates the application of the logistic regression model. | lld:pubmed |
| pubmed-article:10567877 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10567877 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10567877 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10567877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10567877 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10567877 | pubmed:issn | 1010-4283 | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:CarreteroPP | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:MolinaRR | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:FilellaXX | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:BallestaA MAM | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:AlcoverJJ | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:QuintóLL | lld:pubmed |
| pubmed-article:10567877 | pubmed:author | pubmed-author:Bosch-Capblan... | lld:pubmed |
| pubmed-article:10567877 | pubmed:copyrightInfo | Copyright 1999 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:10567877 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10567877 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:10567877 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10567877 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10567877 | pubmed:pagination | 312-8 | lld:pubmed |
| pubmed-article:10567877 | pubmed:dateRevised | 2010-1-15 | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:meshHeading | pubmed-meshheading:10567877... | lld:pubmed |
| pubmed-article:10567877 | pubmed:articleTitle | Evaluation of a multivariate prostate-specific antigen and percentage of free prostate-specific antigen logistic regression model in the diagnosis of prostate cancer. | lld:pubmed |
| pubmed-article:10567877 | pubmed:affiliation | Department of Clinical Biochemistry (Unit for Cancer Research), 'Institut d'Investigacions Biomèdiques August Pi i Sunyer', Hospital Clínic, Barcelona, Spain. xfilella@medicina.ub.es | lld:pubmed |
| pubmed-article:10567877 | pubmed:publicationType | Journal Article | lld:pubmed |
